Top Markets
Coin of the day
Petros Pharmaceuticals, Inc. Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

PTPI
Clasificación en acciones #40451
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male... Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Precio por acción
$0.0034
Capitalización bursátil
$144.07K
Cambio (1 día)
13.33%
Cambio (1 año)
-88.67%
País
US
Comercio Petros Pharmaceuticals, Inc. (PTPI)

Categoría

Historial de rendimiento por dividendo de Petros Pharmaceuticals, Inc. (PTPI)
Rendimiento por dividendo (TTM) de Petros Pharmaceuticals, Inc. (símbolo bursátil: PTPI) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Petros Pharmaceuticals, Inc. (PTPI) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras